Zurcher Kantonalbank (Zurich Cantonalbank) Bristol Myers Squibb CO Transaction History
Zurcher Kantonalbank (Zurich Cantonalbank)
- $34.1 Billion
- Q4 2024
A detailed history of Zurcher Kantonalbank (Zurich Cantonalbank) transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Zurcher Kantonalbank (Zurich Cantonalbank) holds 1,413,649 shares of BMY stock, worth $83.1 Million. This represents 0.23% of its overall portfolio holdings.
Number of Shares
1,413,649
Previous 1,392,991
1.48%
Holding current value
$83.1 Million
Previous $72.1 Million
10.91%
% of portfolio
0.23%
Previous 0.22%
Shares
30 transactions
Others Institutions Holding BMY
# of Institutions
2,754Shares Held
1.57BCall Options Held
28MPut Options Held
28.7M-
Vanguard Group Inc Valley Forge, PA190MShares$11.2 Billion0.19% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.33 Billion0.15% of portfolio
-
Jpmorgan Chase & CO New York, NY96MShares$5.65 Billion0.44% of portfolio
-
State Street Corp Boston, MA95.1MShares$5.59 Billion0.22% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.55 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $125B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...